Articles by Ceng Hui

Chief Physician · Wuhan City Sixth Hospital
← Back to profile
Disease Adults

Chronic Myeloid Leukemia: NCCN 2025 Guidance

CML is a BCR::ABL1-driven leukemia usually controlled long term with tyrosine kinase inhibitors, regular molecular monitoring, and…

8 min read Updated 2025-01-01
Disease Adults

Hodgkin Lymphoma: NCCN 2025 Guidance

Hodgkin lymphoma is a treatable lymphoid cancer staged by PET/CT; most patients are cured with chemotherapy, with or without radiation.

8 min read Updated 2025-01-01
Disease Adults

Castleman Disease: NCCN 2025 Guidance

Castleman disease is a rare lymphoproliferation with unicentric and multicentric forms needing tailored, often specialist, therapy.

8 min read Updated 2025-01-01
Disease Adults

Acute Myeloid Leukemia: NCCN 2025 Guidance

AML is an aggressive adult leukemia classified by genetics; intensive or lower-intensity therapy is chosen by fitness and risk.

8 min read Updated 2025-01-01
Disease Adults

Polycythemia Vera: 2025 Guidance

Polycythemia vera is a blood disorder causing excess red cells and clot risk, managed by phlebotomy, aspirin, and cytoreductive therapy…

8 min read Updated 2025-01-01

Medical disclaimer. iMedCompanion is not a medical provider and does not diagnose, treat or prescribe. All information on this website is general in nature and provided for reference only. It is not a substitute for professional medical advice. Always consult a qualified physician about your own condition.

Live Chat